Archives of Neurology · 1979 · 39 citations · 4 references
MedicinePharmacologyPharmacotherapyClinical NeuroscienceClinical PharmacologyNeuropharmacologyAmyotrophic Lateral SclerosisNeurodegenerative Disease PharmacologyNeurodegenerative Disease PharmacotherapyNeurodegenerative DiseasesNeurodegenerative DisordersSpasticity PharmacotherapyAmyotrophic Lateral Sclerosis PathologyOral Antispastic AgentsOral Antispasticity Medications
A trial of the antispastic drug baclofen was made in amyotrophic lateral sclerosis. Some patients noted reduction of tonus and spasticity; but others had no benefit, nor was the course of the disease altered by long-term administration of baclofen. No major side effects occurred.
4
The administration of guanidine in amyotrophic lateral sclerosis
FORBES H. NORRIS, Philip R. Calanchini, Robert J. Fallat et al. · Neurology · 1974 · 284 citations
Antagonism between Lioresal and substance P in rat spinal cord
Koji Saito, Shiro Konishi, Masanori Otsuka · Brain Research · 1975 · 177 citations
Baclofen, A New Antispastic Drug
Barry A. Sachais · Archives of Neurology · 1977 · 104 citations
Pharmacy, Neurology, Pharmacotherapy +15